APA (7th ed.) Citation

D, C., R, B., J, J., S, M., N, S., JMB, S., . . . SR, J. (2026). Extracellular matrix deposition drives disease progression and reduces rapamycin response in lymphangioleiomyomatosis. The European respiratory journal, 67(5), . https://doi.org/10.1183/13993003.00492-2025

Chicago Style (17th ed.) Citation

D, Clements, et al. "Extracellular Matrix Deposition Drives Disease Progression and Reduces Rapamycin Response in Lymphangioleiomyomatosis." The European Respiratory Journal 67, no. 5 (2026). https://doi.org/10.1183/13993003.00492-2025.

MLA (9th ed.) Citation

D, Clements, et al. "Extracellular Matrix Deposition Drives Disease Progression and Reduces Rapamycin Response in Lymphangioleiomyomatosis." The European Respiratory Journal, vol. 67, no. 5, 2026, https://doi.org/10.1183/13993003.00492-2025.